The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Also: Best digital notebooks of 2025 Drawing tablets come in two main forms: pen displays, which feature built-in screens for immersive experiences, and pen tablets. These require an external ...

Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies US, NY, UNITED STATES, January 31, 2025 /EINPresswire ...

Since the Adonit Mark is less precise than other premium pen competitors, this stylus is best for casual note-taking, as opposed to more detailed sketching. One thing’s for certain: at this ...

We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insulins that are being discontinued and some are where there is a temporary shortage. Here’s the ...

Tala Motazedi, a queer screenwriter from Iran, has had a very busy year indeed as the PEN Writer-in-Residence at George Brown College. Her work at the College began in September. … ...